Nikola Corporation’s stock plummeted after announcing a securities purchase agreement and a mixed shelf offering. Meanwhile, Alzamend Neuro surged 262% on news of a partnership with Massachusetts General Hospital for a Phase II clinical study of its PTSD treatment. Other notable movers include Virax Biolabs, Applied DNA Sciences, and Sonder Holdings.